Results from our #AIMS study in @SciReports establish our #AtomNet AI platform as a viable alternative to high-throughput screening. Read about the largest and most comprehensive virtual HTS campaign to date .#AI #drugdiscovery #pharma #biotech #318targets.

Welcome Dr. Neely Mozaffarian, MD, PhD, our new Chief Medical Officer! Together, we're pushing the boundaries of healthcare innovation. #AI #Healthcare #TYK2Inhibition #Innovation #Atomwise.

📷 Big News from Atomwise! We're proud to announce our first AI-Driven Development Candidate, focused on TYK2 Inhibition. 📷.

TOMORROW! Greg Friedland, Sr. Principal Software Engineer at @Atomwise will be presenting "Complementary Methods for Exploring Ultra-large Combinatorial Synthesis Libraries in Fragment-space," at the ACS Fall Symposium on 8/16/23. Don't miss this one! .

Greg Friedland, Sr. Principal Software Engineer at @Atomwise will be presenting "Complementary Methods for Exploring Ultra-large Combinatorial Synthesis Libraries in Fragment-space," at the ACS Fall Symposium on 8/16/23. You won't want to miss this! .

Tomorrow is the day! @HvandenBedem SVP of @Atomwise is presenting “An Efficient Graph Generative Model for Navigating Ultra-Large Combinatorial Synthesis Libraries.” at the DrugSpace Virtual Symposium - Wed. May 24th at 12:15-12:45 pm EST. #AI #research

Register free NOW! @HvandenBedem SVP of @Atomwise is presenting “An Efficient Graph Generative Model for Navigating Ultra-Large Combinatorial Synthesis Libraries.” at the DrugSpace Virtual Symposium - Wed. May 24th at 12:15-12:45 pm EST. #AI #research

Download Saulo de Oliveira's #ACSFALL2022 presentation, "Allosteric Hit Discovery for Phosphatases with AtomNet® Virtual Screens.". #AI #DrugDiscovery

Download Atomwise scientist Aryan Pedawi's #ACSFALL2022 presentation, "Towards computationally efficient graph generative models for molecular research." .#AI #DrugDiscovery.

We are pleased to announce that @gavin_hirst has joined Atomwise as CSO! With more than 30 years of expertise in pharma and biotech, he will set our company’s strategic vision for drug discovery and oversee our R&D pipeline.

We foster an environment where Atoms are able to break through boundaries. ⚛️. Check out our open roles in #Biology, #ProjectManagement, #AllianceManagement and #BusinessDevelopment. ➡️ .#hiring #pharma #biotech

Happening Today! Don't miss Saulo de Oliveira's #ACSFALL2022 presentation August 24, 2022 from 3:45 - 4:15 pm CT in a hybrid session, in-person at S401a - McCormick Place Convention Center.

Happening today! Join Atomwise scientist Aryan Pedawi at his #ACSFALL2022 presentation at this hybrid session, 11:15 am - 11:45 am CT, in person at S401a (McCormick Place Convention Center). #AI #DrugDiscovery.

Atomwise scientist Stephanie Hare, a past #WCCAward winner gives an invited talk at the #ACSFALL2022 meeting TODAY, August 24, 2022 in a hybrid session from 8:55 AM - 9:25 AM CT in-person at Regency E (Hyatt Regency McCormick Place).

#Atoms are amazing! Atom @Saulo de Oliveira shares progress on using #AI #HTS for #drugdiscovery in his #ACSFALL2022 presentation, Allosteric Hit Discovery for Phosphatases with AtomNet® Virtual Screens.

Atoms are innovative. Join Atomwise scientist Aryan Pedawi at his #ACSFALL2022 presentation, "Towards computationally efficient graph generative models for molecular search" .#AI #DrugDiscovery.

Atomwise CEO Abraham Heifets: “Our mission is to use our unique technology to make better medicines, faster, by unlocking targets that have been inaccessible to traditional small molecule discovery approaches.” (7/7)

“Together, we aim at making the drug discovery process more efficient and effective in particular when very limited information is available to support drug design.” — Frank Nestle (6/7).

Sanofi CSO Frank Nestle: “We are excited to partner with Atomwise, given their leadership in the field of virtual screening and AI-based molecular design.” (5/7).